WET AMD Phase 2 Clinical Trial – DAVIO 2

Clinical Trials - EYP-1901

Phase 1 DAVIO Clinical Trial Results in Wet AMD

Phase 1 DAVIO clinical trial demonstrated a favorable safety profile, meeting the primary safety endpoint

Phase 1 DAVIO Clinical Trial In Wet AMD – Subgroup Analysis

EYP-1901 Is Advancing As A Potential Maintenance Therapy In Wet AMD – “Treat to Maintain”

WET AMD Phase 2 Clinical Trial – DAVIO 2

The Phase 2 DAVIO 2 clinical trial for EYP-1901 in wet AMD was designed to support initiation of Phase 3 clinical trials in 2H 2024

Non-proliferative Diabetic Retinopathy – Phase 2 Clinical Trial (PAVIA)

Randomized Double-Masked Single Injection With Sham Control As A 9-Month Treatment In NPDR